05/06/2023Published by Fondazione Gianni Bonadonna at 05/06/2023Categories Events UncategorizedAtezolizumab and carboplatin in metastatic lobular breast cancer
29/05/2023Published by Fondazione Gianni Bonadonna at 29/05/2023Categories Events UncategorizedOlaparib in metastatic prostate cancer with BRCA1/2 mutations
19/05/2023Published by Fondazione Gianni Bonadonna at 19/05/2023Categories Events UncategorizedThe fellowships in memory of Gianni Bonadonna: an opportunity for growth
15/05/2023Published by Fondazione Gianni Bonadonna at 15/05/2023Categories Events UncategorizedAn immunotherapy combination for colorectal cancer
08/05/2023Published by Fondazione Gianni Bonadonna at 08/05/2023Categories Events UncategorizedPrognostic value of ctDNA in triple-negative breast cancer
02/05/2023Published by Fondazione Gianni Bonadonna at 02/05/2023Categories Events UncategorizedSotorasib or docetaxel in KRASG12C-mutated non-small-cell lung cancer
24/04/2023Published by Fondazione Gianni Bonadonna at 24/04/2023Categories Events UncategorizedNeoadjuvant/adjuvant or adjuvant pembrolizumab in melanoma
17/04/2023Published by Fondazione Gianni Bonadonna at 17/04/2023Categories Events UncategorizedRetinoic acid sensitivity in breast cancer
11/04/2023Published by Fondazione Gianni Bonadonna at 11/04/2023Categories Events UncategorizedAdjuvant osimertinib in non-small-cell lung cancer
